Baystreet Staff -

Renowned Veterinarian and Veterinary Cannabinoid Expert Joins True Leaf

[ACCESSWIRE]

VANCOUVER, BC / ACCESSWIRE / May 21, 2015 / True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA.F). One of North America's foremost holistic veterinarians and a world expert on cannabis and its medicinal benefits for pets is joining True Leaf Medicine International's advisory board, the company announced today.

Dr. Robert Silver of Boulder, Colorado, will provide True Leaf with knowledge and guidance as it develops cannabinoid-based therapies for animal and pet health.

Dr. Silver is a 1982 graduate of Colorado State University's College of Veterinary Medicine, and has focused his veterinary career on blending holistic therapies such as herbal and nutraceutical supplements with conventional medical treatments. In his clinical practice, Dr. Silver is sought after by owners who have questions regarding the potential of therapeutic cannabinoids for their pets' chronic and debilitating conditions that resist conventional treatment alone.

Dr. Silver has been on the cutting edge of integrating evidence-based alternative medicine with conventional veterinary medicine. He places a strong emphasis on wholesome nutrition as a basic foundation for optimal pet health, and has success combining nutraceuticals, botanicals, acupuncture and laser therapy with pharmaceuticals and surgery.

Darcy Bomford, CEO of True Leaf, said Dr. Silver's depth of knowledge is unmatched. "He will provide True Leaf with critical expertise as we launch our new pet care website and develop hemp and CBD products for pets."

Commented Dr. Silver, "I have been very impressed with the scope of True Leaf's business plan, and particularly impressed with the integrity and vision of Mr. Bomford. I look forward to helping True Leaf establish a truly vertically-integrated company that grows, processes and manufactures the highest quality cannabis extracts for the pet and veterinary markets."

Dr. Silver was certified in acupuncture by the International Veterinary Acupuncture Society (IVAS) in 1993, and currently serves on the Scientific Advisory Board of the Animal Supplement Council and is the incoming president of the Veterinary Botanical Medical Association. Dr. Silver has served as a member of the Board of Directors of the American Holistic Veterinary Medical Association and was president of the Rocky Mountain Veterinary Holistic Association for three terms in the late 1990s. Dr. Silver travels and speaks widely to veterinary audiences around the world on the subject of integrating alternative therapies with conventional medicine.

Dr. Silver's appointment aligns with True Leaf's Quality of Life vision as it awaits the approval of its Marihuana for Medicinal Purposes Regulations (MMPR) license application in Canada. The company has made a strategic decision to enter the $53 billion pet industry with a line of pet products focused on hemp nutrition. Initially, True Leaf will market soft chews and supplements through direct, pet and natural health channels in Canada and the US. Ultimately it hopes to market a cannabis-based animal drug after pilot trials and regulatory approvals have been satisfied.

About True Leaf International Ltd:

True Leaf Medicine International Ltd. has filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a licensed producer with a facility located in the Village of Lumby, BC. The company has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting a 'ready-to-build' approval.

For more information, please see True Leaf's website at www.trueleaf.com.

For more information contact:

Media

Paul Sullivan
BreakThrough Communications
O: 604-685-4742
M: 604-603-7358
p.sullivan@breakthroughpr.com

Investor Inquiries

Kevin Bottomley
Director
778-389-9933
kevin@trueleaf.com

FORWARD LOOKING INFORMATION

This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.

SOURCE: True Leaf Medicine International Ltd.